NCT04464681 - Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

November 28, 2020

Study Completion Date

November 30, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

M201-A Injection

Active Substance: M201-A Route of administration: continuous intravenous injection

DRUG

Placebo

Placebo: M201-A Placebo Route of administration: continuous intravenous injection

Trial Locations (1)

Clinical Trial Center, Department of Research, KITASATO UNIVERSITY KITASATO INSTITUTE HOSPITAL, Tokyo